Skip to content

Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion SNAP Trial

Clinical Study of the Amedica Corporation Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01557829
Acronym
SNAP
Enrollment
100
Registered
2012-03-20
Start date
2012-02-29
Completion date
2017-03-31
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Spondylolisthesis, Disc Degeneration of Pfirrmann Grade III or Greater, Isthmic Spondylolisthesis of Grade I or II

Keywords

spondylolisthesis, disc degeneration, lumbar interbody fusion, randomized controlled trial, ceramic interbody spacer

Brief summary

This study randomizes degenerative spondylolisthesis and/or degenerative disc patients into two groups: one to receive a new ceramic implant and a control group with a more traditional PEEK plastic implant. The procedure uses a single oblique cage in each group. The study will measure and compare pain and disability improvement with the two implanted devices over a period of two years. The fusion status will also be judged with plane x-rays and one CT scan.

Interventions

DEVICEPosterior lumbar interbody fusion with a PEEK cage

PEEK cage suitable for oblique placement in the lumbar spine

DEVICEPosterior lumbar interbody fusion with a Valeo OL cage

Posterior lumbar interbody fusion with a single Valeo OL ceramic cage.

Sponsors

Amedica Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients age 18-75 years * Chronic low back pain unresponsive to at least six months of conservative care * MRI and standing x-ray evidence of Pfirrmann Grade III or greater disc degeneration and/or degenerative or isthmic spondylolisthesis of Grade I or II

Exclusion criteria

* Osteoporosis * Patients with prior failed fusion at the same level * Degenerative scoliosis * Degenerative spondylolisthesis greater than Grade II * Pregnancy * Psychiatric or mental disease * Alcoholism (drinking more than 5 units per day) * Active infection or prior infection at the surgical site * Active cancer * Insufficient language skills to complete questionnaires * Participation in another study * More than two symptomatic levels that need fusion

Design outcomes

Primary

MeasureTime frameDescription
Roland Morris Disability Questionnaire (RMDQ)12 months post-opThe improvement in the RMDQ over the pre-op RMDQ value for each group will be compared

Secondary

MeasureTime frameDescription
Fusion status3 mo., 6 mo., 12 mo., 24 monthsPlane film radiographs will be used to assess fusion at all four follow-up periods. At 12 months a CT scan will be performed.
Oswestry Disability Index (ODI)12 months post-opThe improvement in the ODI over the pre-op ODI for each Group

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026